首页 | 本学科首页   官方微博 | 高级检索  
   检索      

慢性肾脏病继发性甲状旁腺功能亢进的发病机制研究进展
引用本文:刁宗礼,刘莎,郭王,刘旭,刘文虎.慢性肾脏病继发性甲状旁腺功能亢进的发病机制研究进展[J].现代生物医学进展,2015,15(31):6186-6189.
作者姓名:刁宗礼  刘莎  郭王  刘旭  刘文虎
作者单位:首都医科大学附属北京友谊医院肾内科首都医科大学肾病学系
基金项目:国家自然科学基金项目(81300607);北京市科技计划项目(D131100004713001)
摘    要:继发性甲状旁腺功能亢进是慢性肾脏病的常见并发症,严重影响患者的生活质量和生存率。其发病机制主要包括低钙血症、高磷血症、活性维生素D缺乏、维生素D受体及钙敏感受体表达下调等。近年来,成纤维细胞生长因子23在继发性甲状旁腺功能亢进发病机制中的作用,也越来越受到重视。上述机制均可导致慢性肾脏病患者的甲状旁腺细胞增生,由多克隆增生逐渐发展为单克隆增生、腺瘤等,甲状旁腺功能亢进也逐渐加重。现就慢性肾脏病继发性甲状旁腺功能亢进的发病机制的进展做一综述。

关 键 词:慢性肾脏病  继发性甲状旁腺功能亢进  发病机制

Progress of Pathogenesis of Secondary Hyperparathyroidismin Chronic Kidney Disease
Abstract:Secondary hyperparathyroidism(SHPT) is the common complication in chronic kidney disease which seriously affects the patient''s quality of life and decrease the survival rates. The pathogenesis of this disease includes: hypocalcemia, hyperphosphatemia, the decreased levels of active vitamin D, vitamin D receptor and calcium-sensing receptor. Recently, the elevated level of fibroblast growth factor 23 is also subjected to the value more and more. The above factors can induce parathyroid hyperplasia from polyclone, monoclone, even adenoma, and SHTP may becomemore and more serious. In this review, the progress of pathogenesis in secondary hyperparathyroidismin chronic kidney disease will be introduced.
Keywords:Chronic Kidney Disease  Secondary hyperparathyroidism  Pathogenesis
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号